Status:
UNKNOWN
Impact of Different Treatment in Multivessel Non ST Elevation Myocardial Infarction (NSTEMI) Patients: One Stage Versus Multistaged Percutaneous Coronary Intervention (PCI)
Lead Sponsor:
Gennaro Sardella
Conditions:
Non ST Segment Elevation MI and Unstable Angina
Eligibility:
All Genders
18-95 years
Phase:
PHASE3
Brief Summary
Patients with NSTEMI and multivessel disease will be scheduled to undergo early invasive strategy (PCI within 72 hours) of de novo native coronary artery lesions were considered for recruitment into t...
Eligibility Criteria
Inclusion
- diagnosis of NSTEMI
- presenting with multivessel disease
Exclusion
- patients with cardiogenic shock at presentation
- left main coronary disease (\>50% diameter stenosis)
- previous coronary artery bypass grafting (CABG) surgery
- patients with Syntax Score \>32
- candidated to by-pass surgery
- severe valvular heart disease
- unsuccessful procedures
Key Trial Info
Start Date :
October 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
247 Patients enrolled
Trial Details
Trial ID
NCT01478984
Start Date
October 1 2011
Last Update
November 24 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dept.of Cardiovascular Sciences,Policlinico Umberto I
Rome, Rome, Italy, 00161